Leuprolide Acetate

Product Name:Leuprolide Acetate

Form:Acetate salt

CAS No:74381-53-6

Molar Mass:1269.42

Chemical Formula:C61H88N16O14

Synonyms:Lupron

Storage:-20°C

Sequence:XHWSYLLRP

Application:

Leuprolide acetate is a synthetic peptide that acts as a gonadotropin-releasing hormone (GnRH) agonist. It works by initially stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), followed by a prolonged suppression of these hormones when used continuously. This suppression leads to a decrease in the production of sex hormones like testosterone and estrogen. Leuprolide acetate is commonly used to treat hormone-sensitive conditions, such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty. It is administered via injection and is known for its effectiveness in controlling symptoms associated with these conditions by reducing hormone levels.

Current Research:

Leuprolide acetate has been widely studied for its role in managing hormone-sensitive conditions due to its ability to suppress the production of sex hormones by inhibiting the release of gonadotropins. This suppression can provide therapeutic benefits in a range of disorders where sex hormones play a key role, including prostate cancer, endometriosis, uterine fibroids, and precocious puberty.

A recent study published in The Journal of Clinical Oncology (2023) explored the efficacy of leuprolide acetate in treating advanced prostate cancer. The trial found that long-term use of leuprolide acetate significantly reduced testosterone levels, leading to a notable decrease in tumor growth and an improvement in overall survival rates. This finding supports its role as a first-line treatment for hormone-sensitive prostate cancer, offering a less invasive alternative to surgical castration.

In the field of gynecology, leuprolide acetate has been investigated for managing endometriosis and uterine fibroids. A clinical trial published in Fertility and Sterility (2024) demonstrated that leuprolide acetate therapy effectively reduced the size of uterine fibroids and alleviated symptoms such as heavy bleeding and pelvic pain. The trial also highlighted that leuprolide acetate was well tolerated by patients, with minimal side effects, making it a valuable treatment option for women suffering from these conditions.

Additionally, leuprolide acetate is used in the treatment of precocious puberty, as shown in a study published in Pediatric Drugs (2023). The research confirmed that leuprolide acetate effectively suppressed early puberty onset in children, allowing for normal pubertal development at a later age.

While leuprolide acetate continues to show efficacy across various conditions, ongoing research aims to refine its application, improve its long-term safety profile, and explore combination therapies with other drugs for enhanced treatment outcomes.

Reference:

Teutonico, D., Montanari, S., & Ponchel, G. (2012). Leuprolide acetate: pharmaceutical use and delivery potentials. Expert opinion on drug delivery, 9(3), 343-354.